Lead Sponsor

AbbVie (prior sponsor, Abbott)

Collaborators

Age

18 - 99 years

Sex

ALL

Healthy Volunteers

No

•Adult \>= 18 years old
•Has provided written informed consent allowing the use of their data for the study and providing permission for contact by the study personnel
•Active Psoriatic Arthritis (PsA) with three (3) or more tender and swollen joints as well as active psoriatic skin lesions or confirmed history of psoriasis
•Inadequate response or non-tolerant to current disease-modifying antirheumatic drugs (DMARD) based treatment for PsA

•Currently participating in another prospective study including controlled clinical trials and observational studies
•Patient cannot or will not sign informed consent
•Stable disease with adequate tolerance and response to current treatment and no change in treatment is indicated
•Previous treatment with anti-tumor necrosis factor (anti-TNF) or other biologic agent